Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Left ventricular myocardial dysfunction in arrhythmogenic cardiomyopathy with left ventricular involvement: A door to improving diagnosis.

Vives-Gilabert Y, Sanz-Sánchez J, Molina P, Cebrián A, Igual B, Calvillo-Batllés P, Domingo D, Millet J, Martínez-Dolz L, Castells F, Zorio E.

Int J Cardiol. 2019 Jan 1;274:237-244. doi: 10.1016/j.ijcard.2018.09.024. Epub 2018 Sep 10.

2.

Depression and Anxiety Scores Are Associated with Amygdala Volume in Cushing's Syndrome: Preliminary Study.

Santos A, Granell E, Gómez-Ansón B, Crespo I, Pires P, Vives-Gilabert Y, Valassi E, Webb SM, Resmini E.

Biomed Res Int. 2017;2017:2061935. doi: 10.1155/2017/2061935. Epub 2017 May 18.

3.

White matter involvement on DTI-MRI in Cushing's syndrome relates to mood disturbances and processing speed: a case-control study.

Pires P, Santos A, Vives-Gilabert Y, Webb SM, Sainz-Ruiz A, Resmini E, Crespo I, de Juan-Delago M, Gómez-Anson B.

Pituitary. 2017 Jun;20(3):340-348. doi: 10.1007/s11102-017-0793-y.

PMID:
28332051
4.

Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis.

Hoogman M, Bralten J, Hibar DP, Mennes M, Zwiers MP, Schweren LSJ, van Hulzen KJE, Medland SE, Shumskaya E, Jahanshad N, Zeeuw P, Szekely E, Sudre G, Wolfers T, Onnink AMH, Dammers JT, Mostert JC, Vives-Gilabert Y, Kohls G, Oberwelland E, Seitz J, Schulte-Rüther M, Ambrosino S, Doyle AE, Høvik MF, Dramsdahl M, Tamm L, van Erp TGM, Dale A, Schork A, Conzelmann A, Zierhut K, Baur R, McCarthy H, Yoncheva YN, Cubillo A, Chantiluke K, Mehta MA, Paloyelis Y, Hohmann S, Baumeister S, Bramati I, Mattos P, Tovar-Moll F, Douglas P, Banaschewski T, Brandeis D, Kuntsi J, Asherson P, Rubia K, Kelly C, Martino AD, Milham MP, Castellanos FX, Frodl T, Zentis M, Lesch KP, Reif A, Pauli P, Jernigan TL, Haavik J, Plessen KJ, Lundervold AJ, Hugdahl K, Seidman LJ, Biederman J, Rommelse N, Heslenfeld DJ, Hartman CA, Hoekstra PJ, Oosterlaan J, Polier GV, Konrad K, Vilarroya O, Ramos-Quiroga JA, Soliva JC, Durston S, Buitelaar JK, Faraone SV, Shaw P, Thompson PM, Franke B.

Lancet Psychiatry. 2017 Apr;4(4):310-319. doi: 10.1016/S2215-0366(17)30049-4. Epub 2017 Feb 16.

5.

Altered amplitude of low frequency fluctuations in schizophrenia patients with persistent auditory verbal hallucinations.

Alonso-Solís A, Vives-Gilabert Y, Portella MJ, Rabella M, Grasa EM, Roldán A, Keymer-Gausset A, Molins C, Núñez-Marín F, Gómez-Ansón B, Alvarez E, Corripio I.

Schizophr Res. 2017 Nov;189:97-103. doi: 10.1016/j.schres.2017.01.042. Epub 2017 Jan 28.

PMID:
28139359
6.

Reduced DNA methylation of FKBP5 in Cushing's syndrome.

Resmini E, Santos A, Aulinas A, Webb SM, Vives-Gilabert Y, Cox O, Wand G, Lee RS.

Endocrine. 2016 Dec;54(3):768-777. doi: 10.1007/s12020-016-1083-6. Epub 2016 Sep 23.

PMID:
27664120
7.

NATURALISTIC COURSE OF MAJOR DEPRESSIVE DISORDER PREDICTED BY CLINICAL AND STRUCTURAL NEUROIMAGING DATA: A 5-YEAR FOLLOW-UP.

Serra-Blasco M, de Diego-Adeliño J, Vives-Gilabert Y, Trujols J, Puigdemont D, Carceller-Sindreu M, Pérez V, Álvarez E, Portella MJ.

Depress Anxiety. 2016 Nov;33(11):1055-1064. doi: 10.1002/da.22522. Epub 2016 May 9.

PMID:
27159902
8.

Brain metabolite abnormalities in ventromedial prefrontal cortex are related to duration of hypercortisolism and anxiety in patients with Cushing's syndrome.

Crespo I, Santos A, Gómez-Ansón B, López-Mourelo O, Pires P, Vives-Gilabert Y, Webb SM, Resmini E.

Endocrine. 2016 Sep;53(3):848-56. doi: 10.1007/s12020-016-0963-0. Epub 2016 Apr 21.

PMID:
27103571
9.

Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome.

Santos A, Resmini E, Gómez-Ansón B, Crespo I, Granell E, Valassi E, Pires P, Vives-Gilabert Y, Martínez-Momblán MA, de Juan M, Mataró M, Webb SM.

Eur J Endocrinol. 2015 Dec;173(6):765-75. doi: 10.1530/EJE-15-0600.

10.

Juxtacortical Lesions and Cortical Thinning in Multiple Sclerosis.

Pareto D, Sastre-Garriga J, Auger C, Vives-Gilabert Y, Delgado J, Tintoré M, Montalban X, Rovira A.

AJNR Am J Neuroradiol. 2015 Dec;36(12):2270-6. doi: 10.3174/ajnr.A4485. Epub 2015 Oct 8.

11.

Volumetric MRI study of the habenula in first episode, recurrent and chronic major depression.

Carceller-Sindreu M, de Diego-Adeliño J, Serra-Blasco M, Vives-Gilabert Y, Martín-Blanco A, Puigdemont D, Álvarez E, Pérez V, Portella MJ.

Eur Neuropsychopharmacol. 2015 Nov;25(11):2015-21. doi: 10.1016/j.euroneuro.2015.08.009. Epub 2015 Aug 28.

PMID:
26404405
12.

White matter alterations in the brains of patients with active, remitted, and cured cushing syndrome: a DTI study.

Pires P, Santos A, Vives-Gilabert Y, Webb SM, Sainz-Ruiz A, Resmini E, Crespo I, de Juan-Delago M, Gómez-Anson B.

AJNR Am J Neuroradiol. 2015 Jun;36(6):1043-8. doi: 10.3174/ajnr.A4322. Epub 2015 Apr 30.

13.

Alterations in cerebral white matter and neuropsychology in patients with cirrhosis and falls.

Gómez-Ansón B, Román E, Fernández de Bobadilla R, Pires-Encuentra P, Díaz-Manera J, Núñez F, Martinez-Horta S, Vives-Gilabert Y, Pagonabarraga J, Kulisevsky J, Cordoba J, Guarner C, Soriano G.

PLoS One. 2015 Mar 20;10(3):e0118930. doi: 10.1371/journal.pone.0118930. eCollection 2015.

14.

Resting-state functional connectivity alterations in the default network of schizophrenia patients with persistent auditory verbal hallucinations.

Alonso-Solís A, Vives-Gilabert Y, Grasa E, Portella MJ, Rabella M, Sauras RB, Roldán A, Núñez-Marín F, Gómez-Ansón B, Pérez V, Alvarez E, Corripio I.

Schizophr Res. 2015 Feb;161(2-3):261-8. doi: 10.1016/j.schres.2014.10.047. Epub 2014 Nov 20.

PMID:
25468173
15.

Early Cerebellar Hypometabolism in Patients With Frontotemporal Dementia Carrying the C9orf72 Expansion.

Suárez-Calvet M, Camacho V, Gómez-Ansón B, Antón S, Vives-Gilabert Y, Dols-Icardo O, Clarimón J, Alcolea D, Blesa R, Fortea J, Lleó A.

Alzheimer Dis Assoc Disord. 2015 Oct-Dec;29(4):353-6. doi: 10.1097/WAD.0000000000000056. No abstract available.

PMID:
25203513
16.

Small cerebellar cortex volume in patients with active Cushing's syndrome.

Santos A, Resmini E, Crespo I, Pires P, Vives-Gilabert Y, Granell E, Valassi E, Gómez-Anson B, Martínez-Momblán MA, Mataró M, Webb SM.

Eur J Endocrinol. 2014 Oct;171(4):461-9. doi: 10.1530/EJE-14-0371. Epub 2014 Jul 8.

PMID:
25005936
17.

Improving the execution performance of FreeSurfer : a new scheduled pipeline scheme for optimizing the use of CPU and GPU resources.

Delgado J, Moure JC, Vives-Gilabert Y, Delfino M, Espinosa A, Gómez-Ansón B.

Neuroinformatics. 2014 Jul;12(3):413-21. doi: 10.1007/s12021-013-9214-1.

PMID:
24430512
18.

Striatal volume deficits in children with ADHD who present a poor response to methylphenidate.

Moreno A, Duñó L, Hoekzema E, Picado M, Martín LM, Fauquet J, Vives-Gilabert Y, Bulbena A, Vilarroya O.

Eur Child Adolesc Psychiatry. 2014 Sep;23(9):805-12. doi: 10.1007/s00787-013-0510-y. Epub 2014 Jan 7.

PMID:
24395136
19.

Detection of preclinical neural dysfunction from functional connectivity graphs derived from task fMRI. An example from degeneration.

Vives-Gilabert Y, Abdulkadir A, Kaller CP, Mader W, Wolf RC, Schelter B, Klöppel S.

Psychiatry Res. 2013 Dec 30;214(3):322-30. doi: 10.1016/j.pscychresns.2013.09.009. Epub 2013 Oct 6.

PMID:
24103657
20.

Microstructural white-matter abnormalities associated with treatment resistance, severity and duration of illness in major depression.

de Diego-Adeliño J, Pires P, Gómez-Ansón B, Serra-Blasco M, Vives-Gilabert Y, Puigdemont D, Martín-Blanco A, Alvarez E, Pérez V, Portella MJ.

Psychol Med. 2014 Apr;44(6):1171-82. doi: 10.1017/S003329171300158X. Epub 2013 Aug 21.

PMID:
23962469
21.

Effects of illness duration and treatment resistance on grey matter abnormalities in major depression.

Serra-Blasco M, Portella MJ, Gómez-Ansón B, de Diego-Adeliño J, Vives-Gilabert Y, Puigdemont D, Granell E, Santos A, Alvarez E, Pérez V.

Br J Psychiatry. 2013 Jun;202:434-40. doi: 10.1192/bjp.bp.112.116228. Epub 2013 Apr 25.

PMID:
23620451
22.

Hippocampal dysfunction in cured Cushing's syndrome patients, detected by (1) H-MR-spectroscopy.

Resmini E, Santos A, Gómez-Anson B, López-Mourelo O, Pires P, Vives-Gilabert Y, Crespo I, Portella MJ, de Juan-Delago M, Webb SM.

Clin Endocrinol (Oxf). 2013 Nov;79(5):700-7. doi: 10.1111/cen.12224. Epub 2013 May 27.

PMID:
23594250
23.

Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson's disease.

Pagonabarraga J, Corcuera-Solano I, Vives-Gilabert Y, Llebaria G, García-Sánchez C, Pascual-Sedano B, Delfino M, Kulisevsky J, Gómez-Ansón B.

PLoS One. 2013;8(1):e54980. doi: 10.1371/journal.pone.0054980. Epub 2013 Jan 24.

24.

Predicting dementia development in Parkinson's disease using Bayesian network classifiers.

Morales DA, Vives-Gilabert Y, Gómez-Ansón B, Bengoetxea E, Larrañaga P, Bielza C, Pagonabarraga J, Kulisevsky J, Corcuera-Solano I, Delfino M.

Psychiatry Res. 2013 Aug 30;213(2):92-8. doi: 10.1016/j.pscychresns.2012.06.001. Epub 2012 Nov 11.

PMID:
23149030

Supplemental Content

Loading ...
Support Center